植物來源生物製藥市場：依產品種類、原料類型、適應症及地區分類。

Plant-Based Biologics Market, By Product Type, By Source Type, By Disease Indication, By Geography

出版日期: 2026年07月15日 | 出版商:

Coherent Market Insights | 英文 257 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，植物來源生物製藥市場規模將達到 2,370 萬美元，到 2033 年將達到 3,000 萬美元。預計 2026 年至 2033 年的複合年成長率為 3.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2370萬美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	3.40%	2033年市場規模預測：	3000萬美元

植物來源生物製藥是指利用植物分子農業技術生產的生物製藥，也稱為植物來源生物製藥（PMBs）。植物來源生物製藥的用途和益處遠不止於傳統的疫苗和治療性蛋白質。例如，2015年，植物來源大腸桿菌素被證實是一種有效的食品添加劑，能夠抑制食品中的致病菌。這些大腸桿菌素對所有引起食物中毒的致病性大腸桿菌菌株都具有高效的殺菌作用（即使在低濃度下）。此外，每克純化大腸桿菌素的生產成本約為1美元，使其具有商業性可行性。

市場動態

對治療各種慢性疾病的生物製藥需求不斷成長，以及生物製藥研發投入的增加，預計將顯著推動植物來源生物製藥市場的成長。例如，根據生物技術創新組織（BIO）2015年的報告，超過250種生物製藥和疫苗已經改變了數億患者的生活。此外，據同一資訊來源稱，截至2018年，美國有超過900種針對100多種疾病的生物製藥正在研發中。另外，根據美國製藥商協會（PhRMA）2016年的一份報告，其成員公司在2015年投入了約588億美元用於研發，其中大部分資金由所有美國生物製藥公司用於治療罕見疾病。

許多生物製藥公司正致力於利用菸草、浮萍、苔蘚和苜蓿等各種植物開發植物來源，預計將推動植物來源市場的成長。例如，2015年9月，Mapp Biopharmaceutical, Inc.（簡稱Mapp）的商業合作夥伴LeafBio, Inc.憑藉其正在研發用於治療伊波拉病毒病的植物來源“ZMapp”，獲得了美國食品藥物管理局（FDA）的快速通道簡審類。

然而，植物來源生物製藥生產方面嚴格的監管準則是限制該市場成長的主要因素之一。此外，對污染和環境風險的擔憂也限制了市場成長。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數創建了全球植物來源生物製藥市場主要公司的概況：公司概況、財務表現、產品系列、企業發展地理區域、分銷策略、關鍵發展和策略。
本報告提供的見解將使企業負責人和經營團隊能夠就未來的產品發布、政府措施、技術升級、市場擴張和行銷策略做出明智的決策。
這份「全球植物來源生物製品市場」報告旨在為行業內的眾多相關人員提供參考，包括投資者、產品製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Leaf Expression Systems
- Zea Biosciences
- Planet Biotechnology Inc.
- InVitria
- PlantForm Corporation
- IBIO, Inc.
- Mapp Biopharmaceutical, Inc.
- Pfizer Inc.
- Ventria Bioscience Inc.
- Medicago Inc.
- Eleva GmbH
- Kentucky Bioprocessing, LLC
- Solarvest Bioenergy Inc.
- Byondis BV
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI2394

Plant-Based Biologics Market is estimated to be valued at USD 23.7 Mn in 2026 and is expected to reach USD 30.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 23.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	3.40%	2033 Value Projection:	USD 30.0 Mn

Plant-based biologics are biologic drugs that are manufactured by using plant molecular farming. They are also known as plant-made biologics (PMB). The applications and advantages of plant-based biologics have stretched beyond the traditional boundaries of vaccines and therapeutic proteins. For instance, bacterial colicins derived from plants in 2015 were recently proven effective as food additives for controlling pathogenic bacteria in food products. These colicins are highly effective (even when used in lower concentrations) to fight against all the pathogenic Escherichia coli strains that cause food poisoning. Moreover, it costs around US$ 1.00 for manufacturing one gram of purified colicins, which is commercially viable.

Market Dynamics

The increasing demand for biologics for various chronic diseases and rising investments in R&D for the production of biologics are expected to contribute significantly to the growth of plant-based biologics market. For instance, according to the Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development for over 100 diseases in the U.S. Furthermore, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member companies invested around US$ 58.8 billion in research and development in 2015, of which, majority of the investments was made by all the biopharmaceutical companies in the U.S. for the treatment of rare diseases.

Many biopharmaceutical companies are focused on developing plant-made pharmaceuticals using various plants such as tobacco, duckweed, moss, alfalfa, and other plants, which is expected to propel growth of the plant-based biologics market. For instance, in September 2015, LeafBio, Inc., the commercial partner of Mapp Biopharmaceutical, Inc. (Mapp), was granted fast track designation by the U.S. Food and Drug Administration (FDA) for their plant-made drug ZMapp for the treatment of Ebola virus disease.

However, stringent regulatory guidelines for the production of plant-based biologics is one of the major factors restraining growth of the plant-based biologics market. Moreover, concern regarding contamination and environmental risks is another factor restraining growth of the market.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global plant-based biologics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Leaf Expression Systems, Zea Biosciences, Planet Biotechnology Inc., InVitria, PlantForm Corporation, IBIO, Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience Inc., Medicago Inc., Eleva GmbH, Kentucky Bioprocessing, LLC, Solarvest Bioenergy Inc., and Byondis B.V.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global plant-based biologics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for plant-based biologics market, research and consulting firms, new entrants, and financial analysts.

Market Segmentation

By Product Type (Revenue, USD Mn, 2021-2033)
Monoclonal Antibodies
Alpha Interferon
Glucocerebrosidase
Vaccines
Others
By Source Type (Revenue, USD Mn, 2021-2033)
Carrot
Tobacco Leaves
Rice Seeds
Alfalfa
Others
By Disease Indication (Revenue, USD Mn, 2021-2033)
Gaucher Disease
Tooth Decay
Hepatitis
Lymphoma
Others
By Region (Revenue, USD Mn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Leaf Expression Systems
Zea Biosciences
Planet Biotechnology Inc.
InVitria
PlantForm Corporation
IBIO, Inc.
Mapp Biopharmaceutical, Inc.
Pfizer Inc.
Ventria Bioscience Inc.
Medicago Inc.
Eleva GmbH
Kentucky Bioprocessing, LLC
Solarvest Bioenergy Inc.
Byondis B.V.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Source Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Plant-Based Biologics Market, By Product Type, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Alpha Interferon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Glucocerebrosidase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

5. Global Plant-Based Biologics Market, By Source Type, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Carrot
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Tobacco Leaves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Rice Seeds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Alfalfa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

6. Global Plant-Based Biologics Market, By Disease Indication, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Gaucher Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Tooth Decay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

7. Global Plant-Based Biologics Market, By Region, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Leaf Expression Systems
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Zea Biosciences
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Planet Biotechnology Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- InVitria
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- PlantForm Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- IBIO, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Mapp Biopharmaceutical, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Ventria Bioscience Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Medicago Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Eleva GmbH
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Kentucky Bioprocessing, LLC
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Solarvest Bioenergy Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Byondis B.V.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views